Michael Carducci

13PUBLICATIONS
160CO-AUTHORS
Predictive and prognostic markersCancer geneticsPeripheral nervous systemRadiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 24, 2026
Interconnectedness of Factors Affecting Patient Willingness to Discuss Prostate Cancer Clinical Trials With Physicians.

|Feb 26, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Andrew J Armstrong, Michael J Morris, Wassim Abida

|Feb 19, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing.

Madelyn F Klugman, Hua-Ling Tsai, Yasaman Iranmanesh

|Oct 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching

|Jan 28, 2025
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor.

Rajendra Kumar, Janet Mendonca, Abhishek Shetty

|Oct 07, 2024
Correction: Behavioral Weight Loss Programs for Cancer Survivors Throughout Maryland: Protocol for a Pragmatic Trial and Participant Characteristics.

Gerald J Jerome, Lawrence J Appel, Linda Bunyard

Pageof 3

Frequent Collaborators

5 joint publications

Channing Paller

4 joint publications

Catherine H Marshall

3 joint publications

Elisabeth I Heath

3 joint publications

Mark C Markowski